If you have diabetes and regularly experience numbness, tingling, burning or weakness in your hands, diabetes itself may not be the only possible explanation.
People with diabetes have an increased risk of developing carpal tunnel syndrome (CTS), a condition caused by compression of the median nerve as it passes through the wrist.
A systematic review and meta-analysis involving millions of participants found that, after accounting for potential confounding factors, people with diabetes had approximately 1.69 times the odds of developing carpal tunnel syndrome compared with people without diabetes1.
The relationship is particularly important because carpal tunnel syndrome and diabetic peripheral neuropathy can produce similar symptoms, but they are different conditions and may require different treatment.
Diabetes does not directly cause every case of carpal tunnel syndrome. However, research shows that it is an important risk factor.
A systematic review and meta-analysis by Pourmemari and Shiri evaluated 36 studies. Across studies that controlled for possible confounding variables, diabetes was associated with approximately a 69% increase in the odds of carpal tunnel syndrome or carpal tunnel release. Both Type 1 and Type 2 diabetes were associated with increased risk1.
Long-term population research also supports the association. A Swedish longitudinal cohort study found diabetes to be a major risk factor for compression neuropathies such as CTS, with higher HbA1c and plasma glucose levels associated with increased risk of developing carpal tunnel syndrome2.
In other words, diabetes appears to make the median nerve more vulnerable to compression.
Carpal tunnel syndrome occurs when the median nerve becomes compressed within the carpal tunnel, a relatively confined space at the wrist.
The median nerve supplies sensation to the thumb, index finger, middle finger and part of the ring finger. It also controls several muscles involved in thumb movement.
Diabetes may increase the vulnerability of this nerve through several overlapping mechanisms.
Long-term hyperglycaemia can damage peripheral nerves through several biological processes.
Research into diabetic neuropathy has identified mechanisms including oxidative stress, vascular dysfunction and the accumulation of advanced glycation end products (AGEs). These changes can adversely affect both nerve tissue and the small blood vessels supplying nerves3.
The result may be an increased susceptibility to compression: a nerve already affected by metabolic disease may tolerate mechanical pressure less effectively.
A comprehensive review of carpal tunnel syndrome and diabetes concluded that the increased vulnerability of peripheral nerves in diabetes appears to be an important part of the relationship between the two conditions4.
Persistently elevated glucose can also alter connective tissues.
Glucose can bind to proteins through a process known as non-enzymatic glycation, contributing to AGE formation. These changes have been associated with increased stiffness and alterations in connective tissues in people with diabetes5.
Within the tightly confined carpal tunnel, changes affecting tendons and surrounding tissues may contribute to increased pressure around the median nerve.
Peripheral nerves depend on a network of very small blood vessels for oxygen and nutrients.
Diabetes-related microvascular changes may reduce the ability of nerves to tolerate compression. When mechanical pressure inside the carpal tunnel is added to an already metabolically vulnerable nerve, symptoms may become more likely.
The current evidence therefore suggests that CTS in diabetes is unlikely to have one single mechanism. Rather, metabolic nerve changes, connective-tissue changes, microvascular dysfunction and mechanical compression may interact4.
Typical carpal tunnel symptoms include6:
The little finger is usually not affected by median nerve compression at the wrist, which can provide an important diagnostic clue6.
Persistent numbness, weakness or muscle wasting warrants medical assessment because prolonged compression can lead to more significant median nerve dysfunction6.
This is one of the most important issues for people with diabetes. Diabetic peripheral neuropathy and carpal tunnel syndrome are not the same condition.
A broader nerve disorder associated with diabetes. It frequently begins in the feet and legs before involving the hands and often affects nerves relatively symmetrically.
A focal compression neuropathy. It occurs when one particular nerve, the median nerve, becomes compressed at the wrist.
However, a person can have both conditions at the same time. Research examining people with diabetes demonstrates an important interaction between diabetic peripheral neuropathy and CTS, making careful diagnosis particularly important7.
For that reason, assuming hand tingling is "just diabetic neuropathy" can potentially delay treatment of a separate and potentially treatable nerve compression.
Diagnosis generally begins with a detailed history and physical examination. A clinician may consider:
Because diabetes can produce diffuse peripheral neuropathy, nerve conduction studies and electromyography may be particularly useful when the diagnosis is uncertain or symptoms are complicated4. Ultrasound can also be used in some cases to assess the median nerve.
A comprehensive review of diabetes and CTS recommends careful clinical assessment, with electrophysiological testing where appropriate, because underlying diabetic neuropathy can complicate both diagnosis and assessment of severity4.
Yes. Having diabetes does not mean carpal tunnel syndrome cannot be treated successfully.
Treatment depends on how severe the nerve compression is, how long symptoms have been present and whether there is evidence of nerve damage or muscle weakness.
For relatively mild or intermittent symptoms, a neutral-position wrist splint worn at night may reduce the pressure placed on the median nerve while sleeping. The goal is to prevent prolonged wrist flexion or extension, which can increase pressure inside the carpal tunnel.
Splinting does not correct underlying diabetic nerve damage, but it may reduce symptoms arising from mechanical median nerve compression.
Activities that repeatedly place the wrist in positions that worsen symptoms may need to be temporarily modified.
This does not mean ordinary computer or keyboard use is necessarily the cause of CTS. Instead, modification is aimed at identifying specific positions or activities that provoke an individual's symptoms and reducing them where practical.
A corticosteroid injection into the carpal tunnel can reduce symptoms and may provide short-term relief. However, current American Academy of Orthopaedic Surgeons clinical practice guidelines conclude that corticosteroid injections do not provide long-term improvement for carpal tunnel syndrome8.
An additional consideration for people with diabetes: corticosteroids can temporarily increase blood glucose.
A study of diabetic patients receiving corticosteroid injections in the hand and wrist found a transient increase in blood glucose, with people with Type 1 diabetes and those using insulin more likely to experience this rise9.
This does not necessarily mean someone with diabetes cannot receive a corticosteroid injection. It means glucose management should be discussed with the treating clinician and glucose may need closer monitoring following an injection.
For persistent, moderate or severe nerve compression — particularly where there is constant numbness, significant weakness or evidence of nerve damage — carpal tunnel release may be recommended. During the procedure, the transverse carpal ligament is divided to create more space for the median nerve and reduce pressure.
Importantly, research suggests that people with diabetes can still achieve substantial benefit from carpal tunnel surgery. A systematic review and meta-analysis comparing surgical outcomes in people with and without diabetes found no significant difference in improvement across most measured outcomes. The major difference was poorer recovery in sensory nerve-conduction measures in the diabetes group10.
Other research has similarly demonstrated neurophysiological improvement following carpal tunnel release in people with diabetes, including patients with peripheral neuropathy11.
The presence of significant diabetic neuropathy can, however, influence recovery. Some patients may experience residual symptoms because surgery can relieve compression of the median nerve, but it cannot reverse unrelated diffuse diabetic neuropathy.
Diabetes does warrant additional consideration around surgery, particularly when blood-glucose control is poor.
In one study of patients with diabetes undergoing open carpal tunnel release, an HbA1c of 7.8% or above was associated with higher odds of wound-healing complications12.
A separate study involving 7,958 patients with diabetes found that surgical-site infection rates increased with HbA1c, with an increased-risk threshold occurring in the region of 7–8% HbA1c13.
These figures should not be interpreted as universal cut-offs determining whether someone can or cannot have surgery. Surgical decisions need to account for the patient's overall health, severity of nerve compression, urgency of treatment, diabetes management and individual risk factors.
Good diabetes management is important for overall nerve health, but controlling blood glucose should not be viewed as a substitute for treating significant mechanical median nerve compression.
Higher HbA1c and glucose levels have been associated with greater risk of CTS, supporting the importance of long-term metabolic health2. However, there is currently insufficient evidence to say that lowering HbA1c alone will reverse established carpal tunnel syndrome.
If the median nerve is being mechanically compressed, treatment may still require splinting, injection or surgical decompression depending on severity. For people considering surgery, diabetes management may also be relevant to wound healing and infection risk12,13.
Consider having your symptoms assessed if you experience6:
Early assessment is particularly worthwhile when symptoms are progressing.
Once significant nerve damage has developed, relieving the compression can prevent further deterioration, but complete recovery of sensation or muscle strength may not always be possible6.
There is a well-established association between diabetes and carpal tunnel syndrome1,2. Research suggests diabetes increases the likelihood of CTS, potentially because chronic metabolic changes make peripheral nerves more susceptible to compression while also affecting connective tissue and the nerve's blood supply3–5.
The most important points are:
If hand numbness is being attributed to diabetes but follows a typical median-nerve pattern, assessment for carpal tunnel syndrome may identify a separate and potentially treatable source of symptoms.
Yes. Diabetes is a recognised risk factor for CTS. A large systematic review found approximately 69% higher adjusted odds of CTS among people with diabetes compared with people without diabetes.
Chronic hyperglycaemia can affect peripheral nerves, small blood vessels and connective tissues. These changes may make the median nerve less able to tolerate the pressure created when it becomes compressed inside the carpal tunnel.
Carpal tunnel tends to produce symptoms in the thumb, index, middle and thumb-side of the ring finger and is frequently worse at night. Diabetic peripheral neuropathy is usually more diffuse and commonly begins in the feet. The two conditions can occur simultaneously, so clinical examination and sometimes nerve-conduction testing are needed to distinguish them.
Yes. Diabetes alone does not prevent someone having carpal tunnel release. Studies suggest patients with diabetes generally experience significant improvement following decompression, although recovery may differ when significant diabetic peripheral neuropathy is also present.
Yes. Research has shown that corticosteroid injections into the hand can cause a temporary increase in blood glucose in some people with diabetes, particularly people with Type 1 diabetes and those using insulin.
Good glucose management is important for nerve and general health, but there is insufficient evidence that improving blood glucose alone reverses established mechanical median nerve compression. Significant CTS may require treatment directed specifically at the carpal tunnel.
Connect with diabetes healthcare professionals across Australia
Medical disclaimer: This information is general in nature and does not replace assessment, diagnosis or personalised advice from a qualified health professional.
Last reviewed: August 2026 · Next review due: August 2027
This website content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition.